Marking its 50th anniversary, Nitta Gelatin India (NGIL)—a joint venture between Nitta Gelatin, Japan, and the Kerala State Industrial Development Corporation, has charted a Rs 200-crore expansion plan.

The move includes the commissioning of a new collagen peptide plant, a new gelatin unit, and a corporate headquarters at Kakkanad, Kerala. This positions NGIL to tap into the booming collagen peptide segment, with applications in wellness, joint health, and metabolic care. “Our upgraded facility will allow us to respond to this demand with scale and speed,” said Praveen Venkataramanan, Managing Director, NGIL. With five decades of evolution from ossein manufacturing to pharma-grade gelatin, NGIL now aims to lead in clean-label, functional ingredients.

Currently valued at Rs 500 crore, NGIL expects its turnover to reach Rs 750–800 crore post-expansion in two years. The golden jubilee celebrations on August 2 will also see foundation stone ceremonies for upcoming facilities, reinforcing NGIL’s role in India's health-focused bio-products sector.